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Nuclease resistant extracellular miRNAs have been found in all known biological fluids.
The biological function of extracellular miRNAs remains questionable; however, strong
evidence suggests that these miRNAs can bemore than just byproducts of cellular activity.
Some extracellular miRNA species might carry cell–cell signaling function during various
physiological and pathological processes. In this review, we discuss the state-of-the-art in
the field of intercellular miRNA transport and highlight current theories regarding the origin
and the biological function of extracellular miRNAs.
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INTRODUCTION
MicroRNAs (miRNAs), a subclass of short non-coding RNAs,
are expressed in all eukaryotic cell types and mediate posttran-
scriptional regulation of gene expression (Ambros, 2004; Bartel,
2004). The action of miRNAs is mediated by its binding to the 3′-
untranslated region (3′UTR) of the target mRNAs and thus regu-
lating targeted mRNAs stability and protein synthesis (Ambros,
2004; Bartel, 2004). There have been more than 2000 differ-
ent human miRNA species discovered so far and this amount
is increasing (http://www.mirbase.org/). In humans, endogenous
miRNAs regulate at least 30% of genes (Lewis et al., 2005) and,
thus, coordinate key cellular processes including proliferation,
DNA repair, differentiation, metabolism, and apoptosis (Ambros,
2004; Bartel, 2004; Croce and Calin, 2005). Deregulation of cer-
tain miRNAs’ expression in the cell was consistently observed
during various pathologies including cancers (Lu et al., 2005).
Every miRNA has a unique nucleotide sequence and unique
expression pattern in certain cell type (Lu et al., 2005; Landgraf
et al., 2007).
Several years ago, significant amounts of miRNAwere detected
in all biological fluids including blood plasma, urine, tears,
breast milk, amniotic fluid, cerebrospinal fluid, saliva, and semen
[reviewed in Turchinovich et al. (2012)]. These extracellular cir-
culating miRNAs are surprisingly stable and survive unfavorable
physiological conditions such as extreme variations in pH, boil-
ing, multiple freeze thaw cycles, and extended storage. In contrast
to miRNAs, common RNA species like mRNA, rRNA, and tRNA
are degraded within several seconds after being placed in nuclease
rich extracellular environment (Chen et al., 2008; Turchinovich
et al., 2011). In their pioneering work Valadi et al. reported that
cells in culture transport intracellular miRNAs into the extracel-
lular environment by exosomes (Valadi et al., 2007). This finding
was confirmed in many subsequent reports and mechanisms of
miRNA transfer have been suggested. In this review, we discuss
the state-of-the-art in the field of intercellular miRNA transport,
and particularly the mechanisms involved in this process. We will
highlight actual theories regarding the origin and the biological
function of extracellular circulating miRNAs in body fluids.
miRNA BIOGENESIS AND MODE OF ACTION
All miRNAs are originally generated in the cell nucleus as long
primary miRNAs (pri-miRNAs) transcripts containing 5′cap and
a 3′polyA tail (Lee et al., 2004). The pri-miRNAs are further
cleaved by a microprocessor complex consisting of Drosha and
DGCR8 proteins into ∼70 nt hairpin precursor miRNAs (pre-
miRNAs) (Lee et al., 2003; Landthaler et al., 2004). On the next
step pre-miRNAs are actively transported into the cytoplasm (Yi
et al., 2003) where they cleaved into ∼22 bp miRNA/miRNA∗
duplexes by Dicer/TRBP enzyme complex (Zhang et al., 2002;
Chendrimada et al., 2005). Finally, miRNA/miRNA∗ duplexes
separate leaving one of strands associated with an Argonaute
(AGO) protein (Okamura et al., 2004; Ender and Meister,
2010). This AGO associated “mature” miRNA strand sequence-
specifically binds to complementary mRNAs, promoting their
decay and inhibiting translation (Figure 1). Surprisingly, some
miRNAs activated both translation and steady state levels of tar-
get mRNAs during cell cycle arrest in quiescent mammalian cells
and Xenopus oocytes (Vasudevan et al., 2007; Truesdell et al.,
2012)—a mechanism which is yet to be explained.
Four human AGO proteins (AGO1, AGO2, AGO3, and AGO4)
have been described so far; all of them can mediate both trans-
lation repression of mRNA on ribosomes and mRNA decay in
P-bodies. However, only AGO2 is capable of directly cleaving
mRNA in the cytoplasm (Hock andMeister, 2008). AGO carrying
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FIGURE 1 | The biogenesis of miRNAs starts in the cell nucleus with
generation of primary miRNAs (pri-miRNAs) transcripts. Pri-miRNAs
are cleaved by the microprocessor complex Drosha/DGCR8 into shorter
miRNA precursors (pre-miRNA). The later are transported to the
cytoplasm and further cut by the endonuclease Dicer into ∼22 nt
miRNA/miRNA∗ duplexes. Finally, one of the miRNA/miRNA∗ strands is
incorporated into a protein of the Argonaute family (AGO1, AGO2, AGO3,
or AGO4). The mature miRNA strand eventually serves as the guide for
RISC-mediated mRNA targeting resulting in either mRNA cleavage or
translational interference. Extracellular miRNA can be either solely AGO
protein-associated or additionally encapsulated into apoptotic bodies,
microvesicles, and HDL particles.
miRNA forms the RNA-induced silencing complex (RISC) by
binding to GW182 via C-terminal domain of AGO protein (Lian
et al., 2009; Braun et al., 2013). The RISC can be localized
(1) diffusely in the cytoplasm; (2) in the dense cytoplasmic
structures called GW- or P-bodies—the main localization for
mRNAs which undergo decapping, deadenylation, and degrada-
tion (Kedersha et al., 2005). Importantly, only 1% of cytoplasmic
AGO2 was found in P-bodies whereas the majority was diffusely
distributed elsewhere in the cytoplasm (Leung and Sharp, 2013).
When studying extracellular miRNA the researchers must take
into account the particularities of miRNA biogenesis, its mode of
action and localization in the cell. Importantly, neither mature
miRNAs nor pre-miRNAs were ever found within the cells in
non-protein bound forms.
EXTRACELLULAR miRNA
The pioneering observations that mature miRNAs are also
present in cell-free blood plasma and serum was made in the year
of 2008 by several independent research groups (Chen et al., 2008;
Chim et al., 2008; Lawrie et al., 2008; Mitchell et al., 2008). Later,
the existence of extracellular circulating miRNA in all other bio-
logical fluids was confirmed (Park et al., 2009; Hanke et al., 2010;
Kosaka et al., 2010b; Weber et al., 2010). The mechanism which is
responsible for the nuclease resistance of miRNA outside the cell
remained enigmatic for quite a long period; however, the presence
of miRNAs in the exosomes exported by cells in culture has been
known before (Valadi et al., 2007). The theory that extracellu-
lar miRNA is protected by encapsulation into membrane-vesicles
emerged after Hunter et al. detected miRNAs in peripheral blood
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microvesicles (Hunter et al., 2008). Together with the evidence
that exchange of miRNA (and also mRNA) between cells can be
accomplished through exosome-mediated transfer (Valadi et al.,
2007) the finding of Hunter and co-authors led to a revolutionary
hypothesis—the existence intercellular and inter-organ commu-
nication system in the body by means of microvesicles (MVs)
encapsulated miRNAs.
In 2011, the assumption that only membrane-vesicles encap-
sulated miRNAs are present in biological fluids was challenged by
two independent research groups who demonstrated that 90–99%
of extracellular miRNA are MVs-free and associated with pro-
teins of the AGO family both in blood plasma/serum and cell
culture media (Arroyo et al., 2011; Turchinovich et al., 2011).
The remarkable stability of AGO2 protein in protease rich envi-
ronment elegantly explained the resistance of associated miRNAs
in nucleases containing biological fluids (Turchinovich et al.,
2011).
Since then, accumulated reports have consistently shown that
extracellular miRNAs can be shielded from RNAse degradation
by: (1) packaging in apoptotic bodies, shedding vesicles and exo-
somes; or (2) solely by complexing with AGO proteins (reviewed
in Cortez et al., 2011; Chen et al., 2012; Turchinovich et al., 2012)
(Figure 1). Some miRNA species were also found in purified frac-
tions of high-density lipoprotein (HDL) from human plasma
(Vickers et al., 2011). The existence of HDL-associated miRNAs in
the blood circulation have been recently confirmed byDimmeler’s
group (Wagner et al., 2013), however, the analysedHDL-miRNAs
constituted only minor proportion the total circulating miRNAs.
Finally, synthetic miRNA can be protected from the degrada-
tion by RNAses when mixed with purified nucleophosmin 1
(NPM1) protein in vitro (Wang et al., 2010). Although NPM1
was indeed exported by cells in culture together with miRNA,
neither intracellular nor extracellular miRNA association with
NPM1 has been found in vivo (Wang et al., 2010; Turchinovich
et al., 2011).
THE THEORY OF CELL–CELL COMMUNICATION VIA
EXTRACELLULAR miRNA
The presence of miRNA in the extracellular environment ignited
the hypotheses that cells selectively release miRNAs which medi-
ate cell–cell signaling via paracrine or even endocrine routes
(Valadi et al., 2007; Cortez et al., 2011; Chen et al., 2012).
However, circulating miRNAs bound solely by AGO proteins
are apparently non-specific remnants resulting from physiolog-
ical activity of the cells and cell death (Turchinovich et al.,
2011; Turchinovich and Burwinkel, 2012). Thus, both AGO2 pro-
tein and miRNAs remain stable for prolonged periods after the
parental cells die. Furthermore, there are no indications of either
active release of AGO-miRNA ribonucleoprotein complexes from
cells or their uptake by recipient cells in mammals. The opinion
that many extracellular miRNAs are released non-selectively after
cell death also accords with the fact that upon toxicity in certain
tissues the level of tissue-specific miRNAs in the blood increases
(Laterza et al., 2009; Corsten et al., 2010; Lewis and Jopling, 2010;
Zhang et al., 2010a; Pritchard et al., 2012).
At the same time, a number of independent research groups
have demonstrated that extracellular miRNAs entrapped within
apoptotic bodies and exosomes can be transferred to recipient
cells, alter gene expression and mediate functional effects (Valadi
et al., 2007; Skog et al., 2008; Kosaka et al., 2010a; Pegtel et al.,
2010; Mittelbrunn et al., 2011; Montecalvo et al., 2012). Patterns
of mRNAs in exosomes and their donor cells correlate poorly,
suggesting specific sorting of miRNA “for export” (Valadi et al.,
2007; Skog et al., 2008; Collino et al., 2010; Pigati et al., 2010;
Mittelbrunn et al., 2011). The mechanism behind this sorting
needs to be investigated in more detail, however, certain clues
may lie within the fact that miRNAs, GW182 and AGO pro-
teins co-localize in the compartments which are strongly linked
with endosomes and multivesicular bodies (MVBs) (Gibbings
et al., 2009). Because exosomes are formed in the MVB and also
contain high levels of GW182, these observations may be impor-
tant findings for the understanding of the loading of RNA into
exosomes (Gibbings et al., 2009). It is feasible that AGO-bound
miRNAs which reside in the MVBs become encapsulated ran-
domly into the newly formed exosomes. The fact that different
miRNAs might possess different decay kinetics could partially
account for the fact that certain miRNAs were expressed at higher
levels in extracellular MVs than in the parental cells (Bail et al.,
2010; Krol et al., 2010). Another possible methodological bias
which has to be addressed when comparing extracellular versus
intracellular miRNA profiles include preferential loss of certain
miRNAs during extraction from samples with very low RNA con-
tent (e.g., extracellular fluids) (Kim et al., 2012). Nevertheless,
there is mounting evidence that cells selectively package certain
miRNAs into MVs and actively secrete them. However the exact
mechanisms of vesicular miRNAs sorting and secretion are yet to
be discovered.
Collino and co-authors have demonstrated that MVs exported
by human bone marrow derived mesenchymal stem cells (MSCs)
and liver resident stem cells (HLSCs) indeed contained both
miRNAs and AGO2 protein (Collino et al., 2010). Furthermore,
selected patterns of miRNAs in MVs suggested their spe-
cific compartmentalization. Bioinformatics analysis revealed that
MV-expressed miRNAs could be involved in organ development,
cell survival, cell differentiation, and regulation of the immune
system. The authors further showed that pre-treatment with
the inhibitor of actin polymerization cytochalasin B significantly
reduced the release of MVs from both MSCs and HLSCs (Collino
et al., 2010).
At the same time several research groups have further demon-
strated that exosomal miRNA is released via ceramide-dependent
secretory pathway which is controlled by the enzyme of ceramide
biosynthesis neutral sphingomyelinase (nSMase) (Kosaka et al.,
2010a; Kogure et al., 2011; Mittelbrunn et al., 2011). nSMase
mediates hydrolysis of sphingomyelin to form ceramide and
is indispensable for budding of intracellular vesicles into the
MVB (Trajkovic et al., 2008). Inhibition of nSMase2 with the
small molecule compound GW4869 and the appropriate siRNA
decreased both exosomes and miRNA secretion (Kosaka et al.,
2010a). Consistently, ectopic overexpression of nSMase2 resulted
in higher amounts of extracellular miRNAs (Kosaka et al., 2010a).
An independent group of authors further demonstrated that inhi-
bition of nSMase does not alter intracellular miRNA levels but
reduces miRNA in secreted exosomes (Kogure et al., 2011). While
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these data emphasize the importance of the MVBs and sphin-
gomyelins for miRNA excretion, how exactly the selection and
the loading of specific miRNA into exosomes occurs remains
unknown. Finally, cell targeting has been hypothesized to be
mediated by both exosomal surface proteins and receptors on
the acceptor cells. The putative mechanisms of membrane vesi-
cles uptake can be either direct membrane fusion or endocytosis
(Thery et al., 2002; Cocucci et al., 2009; Simons and Raposo,
2009).
As it was mentioned before, some extracellular miRNA was
co-purified with HDL from human blood (Vickers et al., 2011).
HDL particles were able to deliver miRNAs to recipient cells and
mediate direct targeting of mRNA reporters, while contrary to
exosomes, cellular export of HDL associated miRNAs was nega-
tively regulated by nSMase2. In addition, HDL mediated miRNA
delivery was dependent on a cell surface HDL receptor SRBI,
which binds HDL and mediates the uptake of cholesteryl ester
from HDL. Because small RNAs can easily complex with zwit-
terionic liposomes it was hypothesized that HDL could simply
bind to extracellular plasma miRNAs through divalent cation
bridging (Vickers et al., 2011). This hypothesis, however, assumes
the existence of naked mature miRNAs in the cell. Furthermore,
targeting of mRNA by miRNA requires the latter to be associ-
ated with one of the AGO proteins. Importantly, neither for-
mation of mature miRNAs nor their existence apart from AGO
proteins has been found in vivo. It is, therefore, feasible that
mature miRNAs in exosomes, MVs and HDL particles can be
also bound to AGO proteins. Interestingly, recent evaluation of
the HDL-bound miRNAs isolated from human blood revealed
that the concentration of the most abundantHDL-boundmiRNA
miR-223 contributed to only 8% of the total miR-223 in the
circulation (Wagner et al., 2013). Furthermore, no significant
uptake of HDL-bound miRNAs was observed into endothelial
cells, smooth muscle cells or peripheral blood mononuclear cells
(Wagner et al., 2013).
EXTRACELLULAR miRNAs ASSOCIATEDWITH
MICROVESICLES
Two different types of extracellular MVs described so far are shed-
ding vesicles and exosomes. Exosomes are 30–100 nm in size,
formed within the MVBs and released upon fusion of MVBs
with the plasma membrane (Thery et al., 2002). Unlike exo-
somes, shedding vesicles are formed by outward budding and
fission of the plasma membrane and can vary in size from 0.1
to 1μm (Cocucci et al., 2009). Both types of MVs contain var-
ious proteins, mRNAs and miRNAs in a proportion depending
on the cell from which they originate (Simons and Raposo,
2009; Muralidharan-Chari et al., 2010). Due to the similar size
of exosomes and small shedding vesicles, it is impossible to com-
pletely separate them using differential ultracentrifugation or
other physical methods. It has to be mentioned that most cur-
rent reports describing isolation of MVs-associated extracellular
miRNA rely on using solely ultracentrifugation. As a result, such
experiments inevitably characterize miRNAs in a mixed popu-
lation of two MVs types. However, researchers often refer to
the miRNA isolated from ultra-centrifuged MVs to as “exoso-
mal” miRNA. To our knowledge, there are no reports describing
specifically “shedding vesicles” miRNA or specifically “exosomal”
miRNA.
Exosomes can have many cell-type specific functions which
were attributed predominantly to exosomal surface proteins. For
example, Fas ligand located on the surface of tumor exosomes
induces apoptosis in T lymphocytes (Abusamra et al., 2005).
The biological function of the exosomal RNA in vivo remains
questionable. However, numerous experiments performed on
cultured cells have demonstrated that exosomal miRNAs can
affect gene expression in the recipient cells and mediate a phys-
iological response. A growing body of evidence that miRNAs can
play a role in intercellular communication suggests the paracrine
function of miRNAs which are packed in extracellular MVs
(reviewed in Cortez et al., 2011; Chen et al., 2012; Turchinovich
et al., 2012). The Internet-based database, ExoCarta (http://www.
exocarta.org/), currently lists 463 miRNAs which were found in
exosomes from various cells. In addition, the phenomenon of cell-
cell communication via extracellular miRNAs has been shown in
multiple cell culture models (Table 1).
Collino and co-authors incubated murine tubular epithelial
cells (mTEC) with MSC-derived MVs and confirmed the trans-
port of selected miRNAs by qRT-PCR (Collino et al., 2010). The
abundance of extracellular miRNAs in acceptor cell increased
progressively and correlated with the extent of MV internaliza-
tion. Additionally, incubation of mTEC with MSC-derived MVs
resulted in the reduction of proteins known to be targeted by
some of the enriched miRNAs found in MVs including: PTEN
(targeted by miR-21), cyclin D1 (targeted by miR-100, miR-99a,
and miR-223) and Bcl-2 (targeted by miR-34, miR-181b, and
miR-16).
Microvesicular miRNA from macrophages have been shown
to enhance the invasiveness of breast cancer cells in culture
(Yang et al., 2011). Specifically, macrophages activated by treat-
ments with IL-4 secreted exosomes packed with miR-223 and
were able to promote migration of SKBR3 and MDA-MB-231
breast cancer cells in a transwell invasion assay. Blocking miR-223
with antisense oligonucleotides prevented the observed increase
of invasion capacity. In addition, (1) miR-223 targeted Mef2c
mRNA level was reduced in the exosome-treated cells, and (2) the
expression of β-catenin in the nucleus increased. Based on their
observations, the authors suggested that miR-223 was transferred
from macrophages to breast cancer cells via exosomes where it
affected the Mef2c-β-catenin pathway leading to invasiveness of
the breast cancer cells. For the first time it was suggested that pre-
vention of the exosomal communication between macrophages
and breast cancer cells may help preventing cancer metasta-
sis and being potential target for cancer therapy (Yang et al.,
2011).
The capacity of exosomal miRNA to facilitate viral infec-
tion was reported by Pegtel and co-authors. After infection of
B-lymphoblastoid cells with Epstein-Barr virus (EBV) the viral-
specific miRNAs (EBV-miRNAs) were secreted via exosomes
and affected the expression of EBV-miRNA target gene CXCL11
in co-cultured non-infected cells (Pegtel et al., 2010). Viral
miRNAs were present in both B-cell and non-B-cell fractions
isolated from infected patients, while viral DNA was restricted
to the circulating B-cell population. This indicated that viral
Frontiers in Genetics | Non-Coding RNA June 2013 | Volume 4 | Article 119 | 4
Turchinovich et al. Circulating miRNAs: cell–cell communication function?
Table 1 | Reports demonstrating cell–cell transfer of extracellular miRNA.
Donor cells Acceptor cells miRNA Impact References
MC/9, HMC-1 MC/9 and HMC-1 Multiple miRNAs Not investigated Valadi et al., 2007
THP-1 HMEC-1 cells Overexpressed miR-150 Reduction of miR-150 target c-Myb Zhang et al., 2010b
Increase in HMEC-1 cells migration
EBV-infected B-cells Dendritic cells, HeLa Mature EBV-encoded
miRNAs
Repression of EBV-miRNAs target
CXCL11
Pegtel et al., 2010
COS-7, HEK 293 COS-7, HEK 293 Overexpressed luciferase
siRNA
Repression of luciferase reporter
gene
Kosaka et al., 2010a
COS-7 PC-3M (metastatic
prostate cancer cells)
Overexpressed miR-146a Decrease in proliferation Kosaka et al., 2010a
Repression of miR-146a target
ROCK1
Mesenchymal stem cells Tubular epithelial cells
(mTEC)
Multiple miRNAs Repression of PTEN, cyclin D1,
Bcl-2 proteins
Collino et al., 2010
Macrophages SKBR3 and MDAMB-231
breast cancer cells
Endogenous miR-223 Reduction of miR-223 targeted
Mef2c mRNA
Increased migration of SKBR3 and
MDA-MB-231 cells
Yang et al., 2011
J77 T-cells, primary T-cells Raji B cells (antigen
presenting cells)
Overexpressed miR-335,
endogenous miR-335,
miR-92
Repression of miR-335 targeted
3′-UTR of SOX4 gene
Mittelbrunn et al., 2011
Hep3B Hep3B Endogenous miRNAs
enriched in exosomes
Repression of putative miRNAs
target TAK1
Kogure et al., 2011
Primary mesenchymal
stromal cells
Primary astrocytes and
neurons
Endogenous miR-133b Increase in neurite outgrowth Xin et al., 2012
Primary dendritic cells Primary dendritic cells Endogenous miR-451 and
miR-148a
Repression of luciferase reporter Montecalvo et al., 2012
HUVEC Aortic smooth muscle cell Endogenous miR-143/145 Repression of multiple miR-143/145
targets
Hergenreider et al., 2012
Protection against atherosclerotic
lesion formation
miRNAs transfer from infected to non-infected cells also occurs
in vivo.
Another evidence for functional cell-to-cell miRNA transfer
was found during investigation of the immune synapse for-
mation. Mittelbrunn and co-authors showed that exosomes of
T, B, and dendritic immune cells contained different miRNA
repertoires. Furthermore, miRNAs were transported from T
cells to antigen presenting cells unidirectionally and this trans-
port was antigen-driven (Mittelbrunn et al., 2011). In addition,
transferred miRNAs could modulate gene expression in recipi-
ent cells. The exosomal miRNA-based communication between
different dendritic cells has also been reported, resulting in
the repression of target mRNAs of acceptor dendritic cells
(Montecalvo et al., 2012).
MVs produced by THP1 monocyte/macrophage cells have
been shown to deliver FITC-labeled exogenous miR-150 to
HMEC-1 endothelial cells in culture (Zhang et al., 2010b). In
addition, the delivery of miR-150 correlated with the reduc-
tion of a validated miR-150 target c-Myb and was accompa-
nied with an increase in HMEC-1 cells migration. Treatment
of HMEC-1 cells with specific miR-150 inhibitor abrogated
the observed increase in migration. While the effect was
observed in cultured cells over-expressing miR-150, it remains
unknown whether extracellular levels of endogenous miR-150 in
body fluids is high enough to significantly affect gene expres-
sion in targeted cells in vivo. However, the observation that
plasma MVs isolated from atherosclerotic patients contained
elevated levels of miR-150 ignited a hypothesis that secreted
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endogenous miR-150may play a role in regulating endothelial cell
migration.
Multipotent mesenchymal stromal cells are known to inter-
act with brain parenchymal cells and promote their functional
recovery. In the work of Xin et al., mesenchymal stromal
cells exported miR-133b to the ipsilateral hemisphere. In addi-
tion, miR-133b was highly abundant in the primary cultures
of neurons and astrocytes treated with exosome-enriched frac-
tion released by mesenchymal stromal cells (Xin et al., 2012).
Authors further showed that gap junction intercellular commu-
nication was important for the reported exosome-based miRNA
transfer.
The elegant approach was used by Skog et al. to prove that exo-
somal RNA originating from glioblastoma tumor cells is taken up
by recipient cells (Skog et al., 2008). The authors incorporated
mRNA encoding luciferase reporter into exosomes and moni-
tored luminescence of the recipient cells. Glioblastoma-derived
MVs stimulated proliferation of a human glioma cell line enhanc-
ing further tumor progression. Besides, the authors demonstrated
that serum MVs from glioblastoma patients contain mRNAs and
miRNAs characteristic for gliomas and thus provide a potential
diagnostic use.
Interestingly, the miRNAs from the let-7 family were found
within the exosomes exported from the cultured metastatic gas-
tric cancer cell line AZ-P7a but not from less metastatic cell lines
(Ohshima et al., 2010). Because these miRNAs are known to be
tumor-suppressive, the authors suggested that their elimination
via exosomal export can maintain the oncogenic properties of the
metastatic cells.
Hepatocellular carcinoma cells (HCC) have been shown to
produce exosomes with specific mRNA, miRNA, and protein
content (Kogure et al., 2011). The miRNAs highly enriched
within HCC exosomes were predicted to target transform-
ing growth factor β activated kinase-1 (TAK1), which con-
tributes to local spread, intrahepatic metastases, or multifocal
growth of this type of carcinoma cells (Kogure et al., 2011).
Indeed, HCC-derived exosomes modulated TAK1 expression
and enhanced transformed cell growth in recipient HCC in
culture.
Another cancer-based model was based on human renal can-
cer stem cells. Grange and colleagues reported that a subset of
tumor-initiating MSCs from human renal cell carcinoma released
MVs which triggered angiogenesis and promoted the formation
of a pre-metastatic niche. Importantly, cancer stem cell MVs
contained miRNAs implicated in tumor progression and metas-
tases, and conferred an angiogenic phenotype to normal human
endothelial cells, stimulating their growth and vessel formation
(Grange et al., 2011). However, it remains uninvestigated whether
the miRNAs were responsible for the observed physiological
impact.
Hergenreider and co-authors have found that extracellular
vesicles mediate miRNA transfer from human endothelial cells
to smooth muscle cell in vitro. Specifically, membrane vesicles
secreted by shear-stressed cultured endothelial cells were enriched
with miR-143/145 and modulated gene expression in co-cultured
smooth muscle cells (Hergenreider et al., 2012). Moreover,
miR-143/145-containing vesicles inhibited atherosclerotic lesion
formation in the aorta in a mouse model suggesting a potential
therapy against atherosclerosis.
EXTRACELLULAR miRNAs ASSOCIATEDWITH OTHER
CARRIERS
The products of cell apoptosis (or programmed cell death)
are apoptotic bodies (AB) 1–2μm in size (Kerr et al., 1972;
Hengartner, 2000; Hristov et al., 2004). Together with exosomes
and MVs, some researchers consider ABs as carriers of cell–cell
communication information. Thus, both viral and chromosomal
DNA can be transferred between somatic cells by uptake of the
apoptotic bodies (Holmgren et al., 1999; Bergsmedh et al., 2001).
Zernecke et al. has shown that ABs inhibit atherosclerosis progres-
sion when injected into the blood circulation. The authors also
proposed that miR-126 encapsulated into ABs may be respon-
sible for this protective effect via induction of the chemokine
CXCL12 expression. Indeed ABs contained miR-126 and deliv-
ered miR-126 to recipient vascular cells (Zernecke et al., 2009).
Furthermore, injections of miR-126 containing apoptotic bodies
reduced manifestations of atherosclerosis in mice, while apop-
totic bodies isolated frommiR-126-deficient animals did not have
such an effect. The protective effect was accompanied by ele-
vated expression of CXCL12 in the carotid arteries. It has to be
mentioned that in their experimental model the authors describe
incubation of carotid arteries with relatively high concentrations
of ABs in vitro. It remains to be tested whether physiological levels
of ABs would affect gene expression in a similar manner.
A single report demonstrating that Hepatitis B subviral sur-
face antigen particles (HBsAg) circulating in the Hepatitis B
infected carriers contain both hepatocellular miRNAs and the
AGO2 associated protein (Novellino et al., 2012). Interestingly,
HBsAg associatedmiRNAswere liver-specific (miR-27a, miR-30b,
miR-122, miR-126, and miR-145) as well as immune regula-
tory (miR-106b and miR-223). Computationally predicted target
genes of HBsAg-associated miRNAs includedmolecular pathways
of host-pathogen interactions.
Solely AGO protein-associated miRNA represents by far
the largest class of extracellular miRNA (Arroyo et al., 2011;
Turchinovich et al., 2011; Turchinovich and Burwinkel, 2012).
It was hypothesized that the AGO-ribonucleoprotein complexes
are passively released by all cells after either necrotic or apop-
totic death and remain stable in the extracellular space due to
the high stability of the AGO proteins (Turchinovich et al., 2011;
Turchinovich and Burwinkel, 2012). However, it cannot be com-
pletely excluded that certain cell membrane-associated channels
or receptors mediate specific release of some AGO-miRNA com-
plexes. Interestingly, in C. elegans, cellular uptake of dsRNA is
mediated by a transmembane channel protein SID-1 (Feinberg
and Hunter, 2003). In addition, SID-1 is capable of importing
synthetic miRNA precursors and long hairpin molecules into the
cell (Shih and Hunter, 2011). While the mammalian homologs
of SID proteins do exist, it remains unclear whether they can
uptake RNA from extracellular fluids (Duxbury et al., 2005;
Wolfrum et al., 2007). Furthermore, it remains to be evaluated
whether AGO-bound single stranded mature miRNA can be rec-
ognized by SID proteins in a similar manner as “naked” double
stranded RNA.
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Amazingly, two recent research reports suggest that extra-
cellular miRNA may work in non-canonical ways. Specifically,
either dead cell-released or exosomes secreted miRNAs can act as
signaling molecules to mediate intercellular communication via
binding to extracellular or intracellular Toll-like receptors (TLRs)
(Fabbri et al., 2012; Lehmann et al., 2012). TLRs are a fam-
ily of innate immune system receptors which recognize various
molecular patterns of microbial pathogens and induce antimicro-
bial immune responses (Takeda et al., 2003; Blasius and Beutler,
2010). In 2001, Alexopoulou and co-authors first showed that
dsRNA binds to mammalian TLR-3, consequently leading to the
activation of NF-kappaB and the production of type I inter-
feron response (Alexopoulou et al., 2001). Later, Kleinman and
co-authors reported that cell surface TLR-3 mediates extracellu-
lar siRNA-induced inhibition of angiogenesis independently of
siRNA sequence (Kleinman et al., 2008). The intracellular TLRs
located within endolysosomal compartments can also bind both
double stranded and single stranded nucleic acids derived from
viruses and bacteria (Heil et al., 2004). Among themajor effects of
the activation of intracellular TLRs is the induction of cytokines
essential for innate immune responses. In their work, Fabbri
et al. showed that miR-21 and miR-29a secreted by tumor cells
are capable of binding to murine TLR-7 and human TLR-8 in
immune cells, triggering secretion of prometastatic inflamma-
tory cytokines that ultimately may lead to tumor growth and
metastasis (Fabbri et al., 2012). The authors also concluded that
extracellular miRNAs could function as key regulators of the
tumor microenvironment by acting as paracrine agonists of TLRs
(Fabbri et al., 2012). The recent report of Lehmann and colleagues
provided further evidence in favor of the unconventional role
for the extracellular miRNAs (Lehmann et al., 2012). Intrathecal
injection of extracellular let-7b into the cerebrospinal fluid of
wild-type mice, but not TLR7 knockouts, resulted in activation
of microglia/macrophages and neurodegeneration. Furthermore,
susceptibility to let-7-induced toxicity was restored in neurons
transfected with TLR7 by intrauterine electroporation of Tlr7−/−
embryos. The authors also observed that: (1) dying neurons
released let-7b in vitro; and (2) levels of let-7b were increased
in CSF from patients with Alzheimer’s disease (Lehmann et al.,
2012). These results suggest that extracellular miRNAs can func-
tion as signaling via TLR-7 pathway and contribute to the spread
of CNS damage.
In 2011, Vickers and colleagues reported that HDL com-
plexes isolated from human blood plasma contain miRNA and
could transmit this miRNA into other cells (Vickers et al., 2011).
To examine whether miRNAs carried by HDL can alter gene
expression in distant cells, HDL were isolated from hypercholes-
terolemia patients and healthy subjects. Treatment of human
hepatocytes in culture with HDL derived from hypercholes-
terolemia subjects significantly increased the level of miR-105
in these cells, whereas HDL from healthy controls had no
such effect. Further microarray analysis revealed that HDL from
hypercholesterolemia patients induced profound alterations in
mRNA expression including downregulation of multiple puta-
tive targets of miR-105 in cultured hepatocytes. Contrary to
exosomes, cellular export of HDL-associated miRNAs was nega-
tively regulated by nSMase2. In addition, HDL mediated miRNA
delivery was dependent on a cell surface HDL receptor SRBI,
which binds HDL and mediates the uptake of cholesterylester
from HDL.
CONCLUSION AND FUTURE PERSPECTIVE OF THE FIELD
Despite a number of fascinating examples of intercellular com-
munication via miRNA between cells in culture, the physiological
significance of such paracrine or endocrine impact in the body
is challenged by the fact that the vast majority of the extracel-
lular miRNA are present in membrane-vesicle-free AGO protein-
associated form. Furthermore, the concentration ofmiRNA in the
biological fluids is drastically lower than in the surrounding cells
and might be below the threshold for triggering any significant
physiological effect in vivo (Turchinovich et al., 2011; Williams
et al., 2013). Finally, so far extracellular miRNA trafficking was
consistently shown: (1) only in cultured cells; and (2) only for
several miRNAs.
In their recent report Tuschl group argues against a hormone-
like effect of extracellular miRNA in the blood (Williams et al.,
2013). Deep sequencing experiments revealed that the concentra-
tion of total miRNA in the plasma is within 100 fM range, and the
concentration of any individual miRNA is only a fraction of this
number. However, even the lowest level trace hormones in the
blood are present at least in the picomolar concentration range.
The action of hormones implies receptor-binding and multi-
million amplification of the transmitted signal within the cell.
Unlike hormones miRNAs require intracellular levels of greater
than 1000 copies per cell to exert measureable activity on their
mRNA targets (Williams et al., 2013). Based on these calculations
the authors concluded that it is unlikely that miRNAs can func-
tion as hormones unless they bind to a sensitive miRNA receptor
(Williams et al., 2013).
The paracrine mode of cell–cell signaling for extracellular
miRNA appears to be more feasible. Indeed most, if not all, cur-
rent reports describe evidence of rather short distance commu-
nication of cells via extracellular miRNA. Unlike average miRNA
levels in a biological fluid, the local concentrations of extracellu-
lar miRNAs could suffice to secure the delivery of physiologically
relevant amounts of miRNA from donor to neighboring acceptor
cell. Recent evidence of interaction ofmiRNAwith TLRs provided
additional complexities to distinguish sequence-specific effects of
extracellular miRNA on the targeted mRNAs expression in accep-
tor cells and non-specific response of the innate immune system
(Fabbri et al., 2012; Lehmann et al., 2012).
Despite the fact that extracellular miRNA circulating in bio-
fluids has many properties of promising biomarkers for various
pathological conditions, the concept of miRNA mediated cell-
cell signaling in vertebrates requires further validation. Among
the central questions to be answered remains: (1) whether solely
protein-bound extracellular miRNA can penetrate through the
cell membrane and if so, which mechanisms are responsible; (2)
whether concentrations of MVs-associated miRNAs are above the
physiological limit to mediate any significant para- or endocrine
signaling in vivo; (3) what are the mechanisms of selective
export of miRNAs into extracellular space; (4) how many miR-
NAs out of the total extracellular pool participate in cell–cell
signaling.
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